MARIA PAREDES: Open Payments
NPI 1427386143 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 51 payments from 16 companies in 2025. Trend: 2023 $90 · 2024 $608 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $233 |
| Novo Nordisk Inc | 9 | $157 |
| ABBVIE INC. | 9 | $153 |
| Lilly USA, LLC | 6 | $97 |
| PFIZER INC. | 3 | $60 |
| Ipsen Biopharmaceuticals, Inc | 2 | $60 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Boston Scientific Corporation | 1 | $26 |
Products named: UBRELVY, AIRSUPRA, Wegovy, MOUNJARO, ENHERTU, NURTEC ODT, Onivyde, ZENPEP.
Industry payments across FL — which companies pay providers there.
